Dr Agrawal has designed, funded, and implemented studies on myelodysplastic syndromes, invasive aspergillosis, and chronic lymphocytic leukaemia. His current activities in the field of invasive fungal disease are:
laboratory and clinical studies to improve the diagnosis of IFD in high-risk haematology patients
developing clinical guidelines and integrated care pathways for managing IFD
Promoting best practice and highlighting new developments through educational meetings, e.g. the Fungal Update meeting (www.fungalupdate.org)
Member of the fungal guideline group of ECIL and an author of the ECIL-6 update.
Member of the fungal subgroup of government committee on antimicrobial resistance, ESPAUR.
member of the NHS England Antifungal Stewardship programme group
reviewer for NICE